177 related articles for article (PubMed ID: 36264948)
1. Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort.
Vallejo-Yagüe E; Pfund JN; Burkard T; Clair C; Micheroli R; Möller B; Finckh A; Burden AM
PLoS One; 2022; 17(10):e0275026. PubMed ID: 36264948
[TBL] [Abstract][Full Text] [Related]
2. Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort.
Vallejo-Yagüe E; Burkard T; Micheroli R; Burden AM
BMJ Open; 2022 Sep; 12(9):e061474. PubMed ID: 36115672
[TBL] [Abstract][Full Text] [Related]
3. Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland.
Burkard T; Vallejo-Yagüe E; Hügle T; Finckh A; Burden AM
BMJ Open; 2022 Mar; 12(3):e056352. PubMed ID: 35292498
[TBL] [Abstract][Full Text] [Related]
4. Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs.
Kalweit M; Burden AM; Boedecker J; Hügle T; Burkard T
PLoS Comput Biol; 2023 Jun; 19(6):e1011073. PubMed ID: 37267387
[TBL] [Abstract][Full Text] [Related]
5. Paradigm guiding to tapering or discontinuation of biologic and targeted synthetic disease-modifying antirheumatic drugs in the treatment of patients with rheumatoid arthritis: Results from a local prospective study.
Kaban N; Harman H
Int J Rheum Dis; 2023 Apr; 26(4):689-698. PubMed ID: 36807751
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors.
Arnold S; Jaeger VK; Scherer A; Ciurea A; Walker UA; Kyburz D
Rheumatology (Oxford); 2021 Dec; 61(1):131-138. PubMed ID: 33848332
[TBL] [Abstract][Full Text] [Related]
7. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
8. Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients.
Burkard T; Williams RD; Vallejo-Yagüe E; Hügle T; Finckh A; Kyburz D; Burden AM
Rheumatol Adv Pract; 2021; 5(3):rkab087. PubMed ID: 34888435
[TBL] [Abstract][Full Text] [Related]
9. Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study.
Källmark H; Einarsson JT; Nilsson JÅ; Olofsson T; Saxne T; Geborek P; C Kapetanovic M
Arthritis Rheumatol; 2021 Jul; 73(7):1135-1144. PubMed ID: 33682353
[TBL] [Abstract][Full Text] [Related]
10. A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization.
Emery P; Solem C; Majer I; Cappelleri JC; Tarallo M
Rheumatol Int; 2015 Nov; 35(11):1837-49. PubMed ID: 26164150
[TBL] [Abstract][Full Text] [Related]
11. Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritis.
McDermott GC; DiIorio M; Kawano Y; Jeffway M; MacVicar M; Dahal K; Moon SJ; Seyok T; Coblyn J; Massarotti E; Weinblatt ME; Weisenfeld D; Liao KP
Semin Arthritis Rheum; 2024 Jun; 66():152421. PubMed ID: 38457949
[TBL] [Abstract][Full Text] [Related]
12. Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
Rannio T; Asikainen J; Hannonen P; Yli-Kerttula T; Ekman P; Pirilä L; Kuusalo L; Mali M; Puurtinen-Vilkki M; Kortelainen S; Paltta J; Taimen K; Kauppi M; Laiho K; Nyrhinen S; Mäkinen H; Isomäki P; Uotila T; Aaltonen K; Kautiainen H; Sokka T
Scand J Rheumatol; 2017 Nov; 46(6):425-431. PubMed ID: 28367663
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.
Lee SW; Kim SY; Chang SH
BMC Musculoskelet Disord; 2019 Sep; 20(1):420. PubMed ID: 31506089
[TBL] [Abstract][Full Text] [Related]
14. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
Geng Y; Han J; Deng X; Zhang Z
Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis.
Zhao SS; Kearsley-Fleet L; Bosworth A; Watson K; ; Hyrich KL
Rheumatology (Oxford); 2022 Nov; 61(12):4678-4686. PubMed ID: 35357421
[TBL] [Abstract][Full Text] [Related]
16. Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative.
Li X; Cesta A; Movahedi M; Bombardier C
Arthritis Res Ther; 2022 Nov; 24(1):255. PubMed ID: 36401335
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in clinical characteristics and their influence on clinical outcomes in an observational cohort of patients with rheumatoid arthritis.
Shin S; Park EH; Kang EH; Lee YJ; Song YW; Ha YJ
Joint Bone Spine; 2021 May; 88(3):105124. PubMed ID: 33346105
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
[TBL] [Abstract][Full Text] [Related]
19. Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry.
Koh JH; Lee Y; Kim HA; Kim J; Shin K
Ther Adv Musculoskelet Dis; 2022; 14():1759720X221096363. PubMed ID: 35586514
[TBL] [Abstract][Full Text] [Related]
20. Inclusion of Synovial Tissue-Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment-Naive Rheumatoid Arthritis Patients.
Alivernini S; Tolusso B; Gessi M; Gigante MR; Mannocci A; Petricca L; Perniola S; Di Mario C; Bui L; Fedele AL; Capacci A; Bruno D; Peluso G; La Torre G; Federico F; Ferraccioli G; Gremese E
Arthritis Rheumatol; 2021 Sep; 73(9):1601-1613. PubMed ID: 33750008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
